Top AI Companies With Best Stability & Growth (8,647)

Strong Revenue Growth: Revenue is accelerating with consistent year-over-year gains and guidance pointing to continued expansion through 2026. Record platform activity and rising deal momentum reinforce top-line trajectory.

Customer Loyalty & Retention: Net dollar retention has improved alongside growth in core genomics customers, indicating expanding usage among existing accounts. Record analyses and repeat adoption across cohorts suggest durable engagement.

Market Expansion: Expansion in the U.S. and APAC and the addition of large integrated health systems support a broader geographic and enterprise footprint. Increasing uptake of newer applications strengthens presence across regions.

Profitability: Reported operating earnings reached $3.6 billion in 2025, a 4% increase over 2024, with the company citing record results in both 2024 and 2025. This upward trend indicates expanding earnings power.

Investor Backing & Capital Strength: Surplus grew to $34.7 billion in 2025 (from $33.3 billion in 2024) alongside continued highest-tier financial strength ratings and record policyowner dividends. These signals point to a robust capital base supporting obligations and growth capacity.

Product Line Growth: Insurance sales rose 14% and annuity sales 40% in 2025, and individual life insurance in force climbed to nearly $1.3 trillion. Such broad-based product momentum underpins expansion across core franchises.

Strong Revenue Growth: Recent results show year-over-year increases in revenue and test volumes through 2025 and early 2026. Expanding U.S. adoption and rising Galleri volumes are cited as key contributors.

Strategic Partnerships: Announcements include Epic EHR integration to streamline ordering and results across many health systems, supporting broader access. International and channel collaborations, including Samsung-linked expansion plans, are positioned to extend reach.

Investor Backing & Capital Strength: Post–Illumina spin‑off funding and subsequent equity raises point to a multiyear cash runway. Additional financing provides flexibility to pursue regulatory, reimbursement, and commercialization goals.

Profitability: Margins have expanded even as revenue contracted. Adjusted EBITDA performance held or improved across the last fiscal year and recent quarters.

Healthy Cash Flow: Quarterly free cash flow turned positive and improved sequentially. Full‑year cash generation was positive while management emphasized continued discipline.

Future-Ready Strategy: The company is refocusing on an AI‑native skills platform and divesting a declining instructor‑led training segment. Early platform adoption and AI engagement are positioned as drivers of sustainable growth over time.

Strong Revenue Growth: Public listings like Deloitte’s Technology Fast 500 across multiple years and company disclosures indicating continued momentum into 2024–2026 point to sustained top-line expansion.

Market Expansion: Reports of a London office opening, larger Austin headquarters, and rising global customer reach signal growing geographic footprint and scale.

Product Line Growth: Recent AI-driven launches, the Pyrra acquisition, and partnerships with Riskonnect and Healix broaden the platform into social intelligence and end-to-end travel risk management.

Investor Backing & Capital Strength: On March 18, 2026 the company announced a $27M Series A led by Emergence with Lux and Susa participating, which typically fuels hiring and go-to-market. Feedback suggests this fresh capital coincides with visible customer logos and testimonials that indicate momentum.

Innovation-Driven Growth: The company positions itself as a vertically integrated, AI-native alternative to legacy fund administrators aimed at replacing manual “human duct tape” workflows. Company and investor materials cite roughly $15B in assets administered as an indicator of early commercial uptake, even if self-reported.

Strong Hiring & Retention: LinkedIn lists 11–50 employees with recent hiring updates and several thousand followers, suggesting active team expansion and rising brand visibility typical of a seed-to-Series A startup. Public hiring activity aligns with stated plans to use new funding to grow the team.

Strong Revenue Growth: Q1 2026 results and subsequent guidance point to rapid, accelerating top-line expansion across both government and commercial segments, with U.S. momentum especially pronounced. Management’s decision to raise full‑year outlook reinforces that growth trajectory.

Profitability: The latest quarter showed strong profitability with notable operating leverage and high gross margins. Earnings disclosures indicate scaling economics alongside rapid growth.

Resilient & Sustainable Growth: A sizable backlog and remaining performance obligations provide multi‑period revenue visibility. Recent large government agreements, including a new multi‑year DHS purchasing vehicle, further bolster the pipeline and backlog narrative.

Strong Revenue Growth: Recent disclosures cite surpassing key ARR milestones within the last 18–24 months and a rising mix of larger accounts, indicating sustained top‑line momentum. Feedback suggests growth is occurring alongside an up‑market shift that concentrates revenue in higher‑value customers.

Investor Backing & Capital Strength: A substantial late‑2024 strategic investment at a sizable valuation is described as fueling product development and go‑to‑market execution. This bolsters financial flexibility to fund expansion, acquisitions, and international reach.

Innovation-Driven Growth: Edwin AI’s material share of bookings and the addition of Catchpoint capabilities signal that new AI features and expanded digital experience monitoring are driving adoption. Product momentum is reinforced by initiatives toward “Autonomous IT” and related ecosystem integrations.

Market Expansion: The Captionmax and National Captioning Canada acquisition added live services and Canadian reach. A 2025 rebrand positioned the company toward global video localization and accessibility, indicating a broader go‑to‑market.

Product Line Growth: New offerings include a global linguist marketplace and AI‑enabled localization/EAA compliance solutions in 2025, plus an AI dubbing solution for YouTube creators in April 2026. These launches show expansion into adjacent workflows beyond core captioning.

Investor Backing & Capital Strength: Riverside Partners’ 2019 investment provides institutional sponsorship typical of scale‑up platforms. This backing supported organic investment and acquisitions such as Captionmax.

Investor Backing & Capital Strength: Recent Series B and Series C rounds total significant capital, signaling strong investor confidence and providing resources to scale. The company earmarks this funding to expand its clinical network, AI initiatives, and partnerships.

Strong Revenue Growth: Consistent revenue expansion since launch is highlighted by nine‑figure revenue in 2024 and statements of rapid year‑over‑year growth. Reports also note the company reached profitability in 2025 alongside continued scaling.

Strategic Partnerships: Partnerships with hundreds of health plans, employers, and health systems expand distribution and indicate payer/provider acceptance. Named collaborations (e.g., a health‑system integration) and nationwide in‑network availability broaden access and patient reach.

Market Expansion: Evidence points to new and larger public‑sector deals (a 2025 Navy/APFIT award followed by a 2026 Navy contract) alongside collaborations in life sciences and financial services. Marketplace availability and repeated analyst coverage suggest broader enterprise reach through 2025–2026.

Strategic Partnerships: An equity investment and expanded alignment with UBS, together with integrations and co‑marketing with NVIDIA, Snowflake, and major cloud marketplaces, indicate deepening go‑to‑market leverage. These alliances are positioned to accelerate adoption in regulated industries and the public sector.

Innovation-Driven Growth: Regular platform releases in 2025–2026 (agentic AI and model‑to‑application capabilities) and security/compliance milestones show active product momentum. Continued Gartner Visionary placement and inclusion in Critical Capabilities suggest the roadmap aligns with enterprise needs.

Strong Revenue Growth: Recent announcements cite a breakout year with nearly sevenfold revenue growth leading into the January 2026 raise. Signals also point to production use cases across healthcare, supply chain, finance, and more, indicating expanding commercial traction.

Investor Backing & Capital Strength: On January 29, 2026, the company raised $22 million in Series A financing to scale its platform and delivery model. Evidence of active hiring and newly announced hubs suggests this capital is fueling an expansion build phase.

Strategic Partnerships: Palantir named the company its first Vanguard: Elite partner and announced a large-scale expansion of deployments, indicating strong channel momentum. A new Google Cloud Gemini Enterprise practice further broadens platform collaboration.

Strong Revenue Growth: Evidence indicates the business reported 8x year-over-year growth, millions in ARR, strong month-over-month momentum, and expanding usage alongside a base of 50+ enterprise customers. Expectations to further multiply revenue reinforce a trajectory of accelerated scale.

Investor Backing & Capital Strength: The company raised a $17M Series A followed by a $30M Series B within six months, bringing total funding to $51M from prominent firms including Radical Ventures and Microsoft’s M12. This cadence and investor caliber signal robust capital support for product development and go-to-market expansion.

Innovation-Driven Growth: AI-moderated interviews, agent-led research, and new capabilities such as Visual Intelligence underpin adoption by major enterprises across sectors. Plans to launch an AI-native CXM platform indicate product expansion that broadens use cases and market reach.

Strategic Partnerships: On June 22, 2026, OpenAI’s Patch the Planet launch highlighted Trail of Bits committing its entire security research organization to an initial surge, indicating deep partner alignment and strong demand. This public collaboration underscores momentum with a high‑visibility ecosystem partner.

Innovation-Driven Growth: The firm is emphasizing AI/ML security services and describes an internal shift to “AI‑native” workflows, signaling investment in new capabilities that expand capacity. Publications and tooling around AI‑augmented auditing point to growth powered by innovation.

Strong Hiring & Retention: Trail of Bits announced a Summer 2026 internship intake across software assurance, security engineering, and R&D, indicating near‑term capacity expansion. Additional postings across 2025–2026 for specialized and leadership roles suggest selective but ongoing hiring.

Investor Backing & Capital Strength: Private‑equity firm STG signed a definitive agreement to acquire the company, typically signaling scale and resources to accelerate go‑to‑market and product investment. Prior late‑stage funding and valuation milestones further indicate access to capital and sponsor confidence.

Product Line Growth: The launch of Programmatic CRM with AI agents in 2026 and the expansion of the Da Vinci AI suite into Europe in 2025 show ongoing rollout of new capabilities and features across channels. This sustained shipping cadence suggests continued expansion of the platform’s offering.

Market Expansion: European availability for Da Vinci in 2025 and continued presence in partner content and industry benchmarks in 2026 point to active geographic and ecosystem expansion. Engagement across regions and integrations implies a widening footprint with enterprise buyers.

Strong Revenue Growth: Company announcements cite its “highest revenue quarter ever” in Q4 FY26 and surpassing $1B in billings for FY2024, indicating sustained top‑line momentum. Additional commentary on ARR and bookings momentum reinforces directional growth even as exact rates remain undisclosed.

Innovation-Driven Growth: Recent acquisitions (Scoutbee, Rossum, Tonkean) and AI‑native launches such as Compose and Catalyst signal an expanding, innovation‑led platform. These moves broaden capabilities in supplier intelligence, document processing, and agentic intake/orchestration that can fuel cross‑sell and upsell.

Strong Market Position & Advantage: Placement as a Leader in Gartner’s 2026 Magic Quadrant for Accounts Payable Applications underscores competitive strength in a core module. Continued leader‑level recognitions across S2P/AP evaluations indicate durable category positioning.

Profitability: FY2026 moved to positive GAAP net income with an Adjusted EBITDA margin around the mid‑20s, and Q1 FY2027 maintained a roughly 25% margin. This indicates improved operating leverage and earnings durability.

Healthy Cash Flow: Free cash flow was strong in FY2026 and remained robust in Q1 FY2027. Consistent cash generation supports ongoing investment and resilience.

Future-Ready Strategy: Management is introducing AI‑driven offerings like Scout and an agentic marketing platform as prospective growth engines. Management frames execution and customer adoption as the levers to return ARR to growth.

Investor Backing & Capital Strength: A $372M Series D in June 2024 led by a16z with Sanofi participation provides substantial capital to expand the pipeline and AI capabilities. Reports characterize this as a material valuation step-up and part of a sizable overall funding base.

Strategic Partnerships: A first-of-its-kind AI collaboration with Sanofi and OpenAI and an out‑licensing deal of gusacitinib to Sanofi (up to €545M) indicate strong external validation and access to enterprise-scale deployment. These alliances reinforce market credibility while opening channels for co-development and monetization.

Product Line Growth: Ongoing in‑licensing (e.g., a CNS‑penetrant TYK2 inhibitor and an anti‑CD226 program) and 2026 updates showing rapid Phase 1 initiation suggest a broadening and advancing portfolio. The rebrand and model shift aim to support a faster-moving, diversified pipeline across immunology and related areas.

Strong Market Position & Advantage: Large, company‑reported user counts and references to tens of millions of monthly active writers indicate substantial adoption versus prior years. Third‑party web‑analytics estimates point to recent month‑over‑month traffic gains, reinforcing sustained visibility.

Strategic Partnerships: Placement within Learneo’s multi‑brand portfolio provides cross‑promotion and scale advantages that can aid distribution and retention. The 2021 acquisition signals strategic importance within a larger, growing platform.

Product Line Growth: The offering has expanded beyond paraphrasing into grammar checking, summarization, citation generation, and a co‑writer tool. This broader suite supports deeper engagement and creates additional pathways for growth.

Strong Revenue Growth: Company announcements describe ARR climbing rapidly in 2025, moving from early traction to materially higher recurring revenue within a short window. Public materials describe sustained month‑over‑month gains and a step‑change in scale by late 2025.

Investor Backing & Capital Strength: A late‑2025 Series B led by established venture firms at a substantial reported valuation signals strong external confidence and ample runway. Hiring activity and continued product releases into 2026 reinforce the impression of solid capitalization supporting execution.

Market Expansion: Public claims show customer counts progressing from hundreds earlier in 2025 to four‑figure levels by year‑end, with subsequent materials indicating broader global adoption into 2026. Recognizable enterprise logos and references to usage across many countries suggest widening market reach.